Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model
Open Access
- 1 October 2009
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 17 (10), 1743-1753
- https://doi.org/10.1038/mt.2009.141
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenitaJournal of Dermatological Science, 2008
- Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathwaysBritish Journal of Dermatology, 2008
- Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin ModelJournal of Investigative Dermatology, 2008
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature, 2008
- TNFα blockade in human diseases: An overview of efficacy and safetyClinical Immunology, 2008
- Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyJournal of the American Academy of Dermatology, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2004
- Lentiviral-Mediated RNA InterferenceHuman Gene Therapy, 2002
- Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell linesCancer Genetics and Cytogenetics, 1995